Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2014.11.019
Brazilian Journal of Anesthesiology
Scientific Article

Upper airway morphology in Down Syndrome patients under dexmedetomidine sedation

Morfologia das vias aéreas superiores em pacientes com síndrome de Down sob sedação com dexmedetomidina

Rajeev Subramanyam; Robert Fleck; John McAuliffe; Rupa Radhakrishnan; Dorothy Jung; Mario Patino; Mohamed Mahmoud

http://dx.doi.org/10.1016/j.bjane.2014.11.019 Braz J Anesthesiol, vol.66, n4, p.388-394, 2016
Downloads: 0
Views: 640

Abstract

Abstract Background and objectives: Children with Down Syndrome are vulnerable to significant upper airway obstruction due to relative macroglossia and dynamic airway collapse. The objective of this study was to compare the upper airway dimensions of children with Down Syndrome and obstructive sleep apnea with normal airway under dexmedetomidine sedation. Methods: IRB approval was obtained. In this retrospective study, clinically indicated dynamic sagittal midline magnetic resonance images of the upper airway were obtained under low (1 mcg/kg/h) and high (3 mcg/kg/h) dose dexmedetomidine. Airway anteroposterior diameters and sectional areas were measured as minimum and maximum dimensions by two independent observers at soft palate (nasopharyngeal airway) and at base of the tongue (retroglossal airway). Results and conclusions: Minimum anteroposterior diameter and minimum sectional area at nasopharynx and retroglossal airway were significantly reduced in Down Syndrome compared to normal airway at both low and high dose dexmedetomidine. However, there were no significant differences between low and high dose dexmedetomidine in both Down Syndrome and normal airway. The mean apnea hypopnea index in Down Syndrome was 16 ± 11. Under dexmedetomidine sedation, children with Down Syndrome and obstructive sleep apnea when compared to normal airway children show significant reductions in airway dimensions most pronounced at the narrowest points in the nasopharyngeal and retroglossal airways.

Keywords

Airway, Dexmedetomidine, Imaging, Down Syndrome, Obstructive sleep apnea, Sedation

Resumo

Resumo Justificativa e objetivos: As crianças com síndrome de Down (SD) são vulneráveis à obstrução significativa das vias aéreas superiores devido à macroglossia relativa e ao colapso dinâmico das vias aéreas. O objetivo deste estudo foi comparar as dimensões das vias aéreas superiores de crianças com SD e apneia obstrutiva do sono (AOS) com vias aéreas normais (VAN) sob sedação com dexmedetomidina (DEX). Métodos: Aprovação IRB foi obtida. Neste estudo retrospectivo, imagens clinicamente indicadas de ressonância magnética da dinâmica das vias aéreas superiores em plano sagital na linha média foram obtidas sob dose baixa (1 mcg/kg/h) e dose alta (3 mcg/kg/h) de DEX. Os diâmetros anteroposteriores das vias aéreas e as áreas seccionais foram medidas como dimensões mínimas e máximas por dois observadores independentes, no palato mole (região nasofaríngea) e na base da língua (região retroglossal). Resultados e conclusões: O diâmetro mínimo anteroposterior e a área seccional mínima das regiões nasofaríngea e retroglossal estavam significativamente reduzidos na SD em comparação com VAN, tanto com a dose baixa quanto com a dose alta de DEX. Contudo, não houve diferenças significativas entre as doses baixa e alta de DEX em SD e VAN. A média do índice de apneia e hipopneia na SD foi de 16 ± 11. Sob sedação com DEX, as crianças com SD e AOS, quando comparadas com as crianças com VAN, apresentaram reduções significativas nas dimensões das vias aéreas, mais pronunciadas nos pontos mais estreitos das regiões nasofaríngea e retroglossal.

Palavras-chave

Vias aéreas, Dexmedetomidina, Imagem, Síndrome de Down, Apneia obstrutiva do sono, Sedação

References

Parker SE, Mai CT, Canfield MA. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A: Clin Mol Teratol. 2010;88:1008-16.

Shete MM, Stocks RM, Sebelik ME. Effects of adeno-tonsillectomy on polysomnography patterns in Down syndrome children with obstructive sleep apnea: a comparative study with children without Down syndrome. Int J Pediatr Otorhinolaryngol. 2010;74:241-4.

Guimaraes CV, Donnelly LF, Shott SR. Relative rather than absolute macroglossia in patients with Down syndrome: implications for treatment of obstructive sleep apnea. Pediatr Radiol. 2008;38:1062-7.

Uong EC, McDonough JM, Tayag-Kier CE. Magnetic resonance imaging of the upper airway in children with Down syndrome. Am J Respir Crit Care Med. 2001;163:731-6.

Brown KA. Outcome, risk, and error and the child with obstructive sleep apnea. Paediatr Anaesth. 2011;21:771-80.

Nelson LE, Lu J, Guo T. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428-36.

Hsu YW, Cortinez LI, Robertson KM. Dexmedetomidine pharmacodynamics: Part I: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004;101:1066-76.

Mahmoud M, Gunter J, Donnelly LF. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg. 2009;109:745-53.

Mahmoud M, Radhakrishman R, Gunter J. Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children. Paediatr Anaesth. 2010;20:506-15.

Mahmoud M, Jung D, Salisbury S. Effect of increasing depth of dexmedetomidine and propofol anesthesia on upper airway morphology in children and adolescents with obstructive sleep apnea. J Clin Anesth. 2013;25:529-41.

Malviya S, Voepel-Lewis T, Tait AR. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth. 2002;88:241-5.

R: a language and environment for statistical computing. 2013.

Dyken ME, Lin-Dyken DC, Poulton S. Prospective polysomnographic analysis of obstructive sleep apnea in Down syndrome. Arch Pediatr Adolesc Med. 2003;157:655-60.

Hillman DR, Walsh JH, Maddison KJ. Evolution of changes in upper airway collapsibility during slow induction of anesthesia with propofol. Anesthesiology. 2009;111:63-71.

Donnelly LF, Shott SR, LaRose CR. Causes of persistent obstructive sleep apnea despite previous tonsillectomy and adenoidectomy in children with Down syndrome as depicted on static and dynamic cine MRI. AJR Am J Roentgenol. 2004;183:175-81.

Fricke BL, Donnelly LF, Shott SR. Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls. Pediatr Radiol. 2006;36:518-23.

Fung E, Witmans M, Ghosh M. Upper airway findings in children with Down syndrome on sleep nasopharyngoscopy: case-control study. J Otolaryngol Head Neck Surg. 2012;41:138-44.

Fogel RB, Trinder J, Malhotra A. Within-breath control of genioglossal muscle activation in humans: effect of sleep-wake state. J Physiol. 2003;550:899-910.

Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest. 1992;89:1571-9.

Arens R, McDonough JM, Costarino AT. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2001;164:698-703.

Abbott MB, Donnelly LF, Dardzinski BJ. Obstructive sleep apnea: MR imaging volume segmentation analysis. Radiology. 2004;232:889-95.

Mihaescu M, Murugappan S, Gutmark E. Computational fluid dynamics analysis of upper airway reconstructed from magnetic resonance imaging data. Ann Otol Rhinol Laryngol. 2008;117:303-9.

Chien MY, Wu YT, Lee PL. Inspiratory muscle dysfunction in patients with severe obstructive sleep apnoea. Eur Respir J. 2010;35:373-80.

Malviya S, Voepel-Lewis T, Tait AR. A comparison of observational and objective measures to differentiate depth of sedation in children from birth to 18 years of age. Anesth Analg. 2006;102:389-94.

5dcd6fc00e8825ca08bf58f1 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections